Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons

Bobba, S., Howard, N. C., Das, S., Ahmed, M., Tang, L., Thirunavukkarasu, S., Larsen, M. H., Mathema, B., Divangahi, M., & Khader, S. A. (2023). Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons. MBio, 14(5). https://doi.org/10.1128/mbio.00946-23
Authors:
Suhas Bobba
Nicole C Howard
Shibali Das
Mushtaq Ahmed
Linrui Tang
Shyamala Thirunavukkarasu
Michelle H Larsen
Barun Mathema
Maziar Divangahi
Shabaana A Khader
Affiliated Authors:
Linrui Tang
Barun Mathema
Columbia Affiliation:
Subjects:
Mycobacterium tuberculosis (MeSH)
Interferon Type I (MeSH)
Tuberculosis (MeSH)
Author Keywords:
mycobacterium tuberculosis
drug-resistant mutations
inflammation
lung infection
type i interferons
elink
Publication Type:
Article
Unique ID:
10.1128/mbio.00946-23
PMID:
37682004
DOI:
10.1128/mbio.00946-23
Journal:
MBio
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: